These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 32853658)

  • 1. Inhibition of neuronal Na
    Peng YS; Wu HT; Lai YC; Chen JL; Yang YC; Kuo CC
    Neuropharmacology; 2020 Nov; 179():108266. PubMed ID: 32853658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of lamotrigine inhibition of Na+ channels in rat hippocampal neurones.
    Kuo CC; Lu L
    Br J Pharmacol; 1997 Jul; 121(6):1231-8. PubMed ID: 9249262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective stabilization of the intermediate inactivated Na
    Lin YC; Lai YC; Lin TH; Yang YC; Kuo CC
    Biochem Pharmacol; 2022 Mar; 197():114928. PubMed ID: 35063442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. V102862 (Co 102862): a potent, broad-spectrum state-dependent blocker of mammalian voltage-gated sodium channels.
    Ilyin VI; Hodges DD; Whittemore ER; Carter RB; Cai SX; Woodward RM
    Br J Pharmacol; 2005 Mar; 144(6):801-12. PubMed ID: 15778702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of lacosamide and classical sodium channel blocking antiepileptic drugs on sodium channel slow inactivation.
    Niespodziany I; Leclère N; Vandenplas C; Foerch P; Wolff C
    J Neurosci Res; 2013 Mar; 91(3):436-43. PubMed ID: 23239147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential block of sensory neuronal voltage-gated sodium channels by lacosamide [(2R)-2-(acetylamino)-N-benzyl-3-methoxypropanamide], lidocaine, and carbamazepine.
    Sheets PL; Heers C; Stoehr T; Cummins TR
    J Pharmacol Exp Ther; 2008 Jul; 326(1):89-99. PubMed ID: 18378801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Slow binding of phenytoin to inactivated sodium channels in rat hippocampal neurons.
    Kuo CC; Bean BP
    Mol Pharmacol; 1994 Oct; 46(4):716-25. PubMed ID: 7969051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lacosamide Inhibition of Nav1.7 Voltage-Gated Sodium Channels: Slow Binding to Fast-Inactivated States.
    Jo S; Bean BP
    Mol Pharmacol; 2017 Apr; 91(4):277-286. PubMed ID: 28119481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of the anticonvulsant lacosamide in experimental and human epilepsy via selective effects on slow Na
    Holtkamp D; Opitz T; Niespodziany I; Wolff C; Beck H
    Epilepsia; 2017 Jan; 58(1):27-41. PubMed ID: 27864845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of lacosamide affinity bait agents that exhibit potent voltage-gated sodium channel blocking properties.
    Park KD; Yang XF; Lee H; Dustrude ET; Wang Y; Khanna R; Kohn H
    ACS Chem Neurosci; 2013 Mar; 4(3):463-74. PubMed ID: 23509982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of the antiepileptic drug lamotrigine with recombinant rat brain type IIA Na+ channels and with native Na+ channels in rat hippocampal neurones.
    Xie X; Lancaster B; Peakman T; Garthwaite J
    Pflugers Arch; 1995 Jul; 430(3):437-46. PubMed ID: 7491269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonism of lidocaine inhibition by open-channel blockers that generate resurgent Na current.
    Bant JS; Aman TK; Raman IM
    J Neurosci; 2013 Mar; 33(11):4976-87. PubMed ID: 23486968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels.
    Errington AC; Stöhr T; Heers C; Lees G
    Mol Pharmacol; 2008 Jan; 73(1):157-69. PubMed ID: 17940193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ranolazine reduces neuronal excitability by interacting with inactivated states of brain sodium channels.
    Kahlig KM; Hirakawa R; Liu L; George AL; Belardinelli L; Rajamani S
    Mol Pharmacol; 2014 Jan; 85(1):162-74. PubMed ID: 24202911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eslicarbazepine and the enhancement of slow inactivation of voltage-gated sodium channels: a comparison with carbamazepine, oxcarbazepine and lacosamide.
    Hebeisen S; Pires N; Loureiro AI; Bonifácio MJ; Palma N; Whyment A; Spanswick D; Soares-da-Silva P
    Neuropharmacology; 2015 Feb; 89():122-35. PubMed ID: 25242737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Block of human cardiac sodium channels by lacosamide: evidence for slow drug binding along the activation pathway.
    Wang GK; Wang SY
    Mol Pharmacol; 2014 May; 85(5):692-702. PubMed ID: 24563546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lacosamide: a new approach to target voltage-gated sodium currents in epileptic disorders.
    Curia G; Biagini G; Perucca E; Avoli M
    CNS Drugs; 2009; 23(7):555-68. PubMed ID: 19552484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional consequences of lidocaine binding to slow-inactivated sodium channels.
    Balser JR; Nuss HB; Romashko DN; Marban E; Tomaselli GF
    J Gen Physiol; 1996 May; 107(5):643-58. PubMed ID: 8740377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A common anticonvulsant binding site for phenytoin, carbamazepine, and lamotrigine in neuronal Na+ channels.
    Kuo CC
    Mol Pharmacol; 1998 Oct; 54(4):712-21. PubMed ID: 9765515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How Can an Na
    Lin YC; Lai YC; Chou P; Hsueh SW; Lin TH; Huang CS; Wang RW; Yang YC; Kuo CC
    Ann Neurol; 2021 Jun; 89(6):1099-1113. PubMed ID: 33745195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.